Baird analyst David Manthey raised the firm’s price target on WM (WM) to $245 from $235 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results as its legacy business performed as expected and the company pointed to a Healthcare ramp ahead.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WM:
- WM price target lowered to $255 from $258 at Raymond James
- Waste Management: Balancing M&A Prospects and Commodity Price Uncertainties with a Hold Rating
- WM Reports Strong Q1 2025 Earnings Growth
- Waste Management’s Earnings Call: Strong Growth Amid Challenges
- WM price target raised to $244 from $240 at BofA